Erkan Kurt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Erkan Kurt has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Linda Kollenburg
Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
4 shared publications Robert van Dongen
Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands
4 shared publications- Dylan Henssen
Department of Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands
3 shared publications Kris Vissers
Radboud University Medical Center, Department of Pain and Palliative Care , Nijmegen, 6525 GA
3 shared publicationsYvonne Engels
Department of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands
3 shared publicationsDylan Henssen
Radboud Univ Nijmegen, Med Ctr, Dept Med Imaging, Nijmegen, Netherlands
2 shared publications
Latest Publications
- Open Access
- 18 April 2026
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 30 (1) , 47
Troubles in the Pocket: Evidence- and Experience-Based Multidisciplinary Expert Consensus Recommendations for Implantable Pulse Generator Placement and Management of Associated Inconveniences
Purpose: More than half of patients treated with neuromodulation experience inconveniences related to the implantable pulse generator (IPG). Despite their significance, there is an absence of standardized guidelines and recommendations minimizing and/or preventing these issues, reinforcing the continuous burden posed by IPG-related inconveniences. This study aims to provide evidence- and experience-based recommendations for preoperative counselling, implantation site, surgical technique, and management strategies, improving IPG-related inconveniences, by combining a comprehensive literature review with insights gathered from global expert meetings on the topic. Methods: In this evidence-and experience-based consensus study, a literature analysis was performed using the PubMed, MEDLINE, and EMBASE databases. Experts’ insights on the topic were systematically collected during various expert-based meetings. Recommendations were developed through an integration of literature evidence and clinical expertise, with the aim of preventing and reducing IPG-related inconveniences. The level of evidence for each recommendation has been assessed using the GRADE system and the degree of consensus was evaluated using an independent expert-analysis. Results: A total of 26 articles, published between 2001 and 2024, were included in the literature search. Twenty-six recommendations were formulated. Outcomes emphasized the importance of thorough preoperative counseling, strategic implant site selection, well-considered surgical technique, and tailored postoperative management in reducing the incidence and severity of IPG-related issues. The level of evidence was low to moderate, while the degree of consensus was high for most of the recommendations proposed in this study. Conclusions: Given the impact of IPG-related inconveniences, clear and practical recommendations are essential for consistent and effective neuromodulation practice.
- 18 April 2026
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 30 (1) , 47
Open AccessTroubles in the Pocket: Evidence- and Experience-Based Multidisciplinary Expert Consensus Recommendations for Implantable Pulse Generator Placement and Management of Associated Inconveniences
Purpose: More than half of patients treated with neuromodulation experience inconveniences related to the implantable pulse generator (IPG). Despite their significance, there is an absence of standardized guidelines and recommendations minimizing and/or preventing these issues, reinforcing the continuous burden posed by IPG-related inconveniences. This study aims to provide evidence- and experience-based recommendations for preoperative counselling, implantation site, surgical technique, and management strategies, improving IPG-related inconveniences, by combining a comprehensive literature review with insights gathered from global expert meetings on the topic. Methods: In this evidence-and experience-based consensus study, a literature analysis was performed using the PubMed, MEDLINE, and EMBASE databases. Experts’ insights on the topic were systematically collected during various expert-based meetings. Recommendations were developed through an integration of literature evidence and clinical expertise, with the aim of preventing and reducing IPG-related inconveniences. The level of evidence for each recommendation has been assessed using the GRADE system and the degree of consensus was evaluated using an independent expert-analysis. Results: A total of 26 articles, published between 2001 and 2024, were included in the literature search. Twenty-six recommendations were formulated. Outcomes emphasized the importance of thorough preoperative counseling, strategic implant site selection, well-considered surgical technique, and tailored postoperative management in reducing the incidence and severity of IPG-related issues. The level of evidence was low to moderate, while the degree of consensus was high for most of the recommendations proposed in this study. Conclusions: Given the impact of IPG-related inconveniences, clear and practical recommendations are essential for consistent and effective neuromodulation practice.
- Open Access
- 1 March 2026
- Vol. 26 (3) , e70123
The Effects of Invasive Motor Cortex Stimulation for Neuropathic Pain: Do We See the Full Picture?
Invasive motor cortex stimulation (iMCS) can be a last-resort treatment of chronic neuropathic pain syndromes. There is evidence that iMCS was found to influence pain intensity, quality of life scores, and pain medication intake in clinical practice. Albeit, qualitative studies published over the last years showed that the expectations and experiences of patients have a significant impact on treatment outcomes. This paper focus on these experiences of chronic neuropathic pain patients treated with iMCS. The aim of this interview study was to map the experiences of patients treated with iMCS in order to evaluate the multidimensional effects of iMCS. Twenty-eight patients with chronic neuropathic pain treated with iMCS between 2005 and 2018 were interviewed individually. All interviews were semi-structured using a predefined topic list. An inductive iterative process was performed during the interviews using the constant comparative method. All interviews were audio-recorded and transcribed verbatim afterwards. Transcripts were coded using direct content analysis. The derived codes were structured into categories and themes. Basic quantitative demographic data were collected, and the decrease in pain intensity after 2 years iMCS was calculated. Content analysis of the interviews revealed ten relevant categories, which could be structured into three themes: 1. Influence of the iMCS procedure on patients' live; 2. Effects of iMCS on quality of life and participation and 3. Acceptance and satisfaction. In total, 32% (8/25) were identified as responders, and 68% (17/25) as non-responders. Most patients (71%, 20/28) indicated they would undergo iMCS again. Three patients deceased before the end of the study. This study suggests that the effects of iMCS should be assessed in a more multidimensional way compared to only the effect on pain as patients confided that the true treatment effect and patient satisfaction were based more on improvements of their quality of life, enabling patients to participate again in society in a meaningful way. In clinical practice, this study emphasizes the need for thorough patient education and realistic expectation management prior to implantation, highlighting both potential benefits and limitations to support informed decision-making.
- 1 March 2026
- Vol. 26 (3) , e70123
Open AccessThe Effects of Invasive Motor Cortex Stimulation for Neuropathic Pain: Do We See the Full Picture?
Invasive motor cortex stimulation (iMCS) can be a last-resort treatment of chronic neuropathic pain syndromes. There is evidence that iMCS was found to influence pain intensity, quality of life scores, and pain medication intake in clinical practice. Albeit, qualitative studies published over the last years showed that the expectations and experiences of patients have a significant impact on treatment outcomes. This paper focus on these experiences of chronic neuropathic pain patients treated with iMCS. The aim of this interview study was to map the experiences of patients treated with iMCS in order to evaluate the multidimensional effects of iMCS. Twenty-eight patients with chronic neuropathic pain treated with iMCS between 2005 and 2018 were interviewed individually. All interviews were semi-structured using a predefined topic list. An inductive iterative process was performed during the interviews using the constant comparative method. All interviews were audio-recorded and transcribed verbatim afterwards. Transcripts were coded using direct content analysis. The derived codes were structured into categories and themes. Basic quantitative demographic data were collected, and the decrease in pain intensity after 2 years iMCS was calculated. Content analysis of the interviews revealed ten relevant categories, which could be structured into three themes: 1. Influence of the iMCS procedure on patients' live; 2. Effects of iMCS on quality of life and participation and 3. Acceptance and satisfaction. In total, 32% (8/25) were identified as responders, and 68% (17/25) as non-responders. Most patients (71%, 20/28) indicated they would undergo iMCS again. Three patients deceased before the end of the study. This study suggests that the effects of iMCS should be assessed in a more multidimensional way compared to only the effect on pain as patients confided that the true treatment effect and patient satisfaction were based more on improvements of their quality of life, enabling patients to participate again in society in a meaningful way. In clinical practice, this study emphasizes the need for thorough patient education and realistic expectation management prior to implantation, highlighting both potential benefits and limitations to support informed decision-making.
- Open Access
- 4 August 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1900
Preoperative Suffering of Patients with Central Neuropathic Pain and Their Expectations Prior to Motor Cortex Stimulation: A Qualitative Study
Objective: This study aimed to improve the understanding of the lives of patients with chronic neuropathic pain planned for invasive motor cortex stimulation (iMCS) and assess their expectations towards this intervention and its impact. Methods: Semi-structured face-to-face interviews were conducted until saturation of data was reached. Patients were recruited from one university medical center in the Netherlands. All interviews were audio-recorded, transcribed verbatim, and subjected to thematic analysis using iterative and inductive coding by two researchers independently. Results: Fifteen patients were included (11 females; mean age 63 ± 9.4 yrs). Analysis of the coded interviews revealed seven themes: (1) the consequences of living with chronic neuropathic pain; (2) loss of autonomy and performing usual activities; (3) balancing energy and mood; (4) intimacy; (5) feeling understood and accepted; (6) meaning of life; and (7) the expectations of iMCS treatment. Conclusions: This is the first qualitative study that describes the suffering of patients with chronic neuropathic pain, and their expectations prior to invasive brain stimulation. Significant themes in the lives of patients with chronic pain have been brought to light. The findings strengthen communication between physicians, caregivers, and patients. Practice Implications: The insights gathered from the interviews create a structured framework for comprehending the values and expectations of patients living with central pain and reveal the impact of symptoms due to the central pain. This knowledge improves the communication between physicians and caregivers on one side and the patient on the other side. Furthermore, the framework enhances the capacity for shared decision-making, particularly in managing expectations related to iMCS.
- 4 August 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (15) , 1900
Open AccessPreoperative Suffering of Patients with Central Neuropathic Pain and Their Expectations Prior to Motor Cortex Stimulation: A Qualitative Study
Objective: This study aimed to improve the understanding of the lives of patients with chronic neuropathic pain planned for invasive motor cortex stimulation (iMCS) and assess their expectations towards this intervention and its impact. Methods: Semi-structured face-to-face interviews were conducted until saturation of data was reached. Patients were recruited from one university medical center in the Netherlands. All interviews were audio-recorded, transcribed verbatim, and subjected to thematic analysis using iterative and inductive coding by two researchers independently. Results: Fifteen patients were included (11 females; mean age 63 ± 9.4 yrs). Analysis of the coded interviews revealed seven themes: (1) the consequences of living with chronic neuropathic pain; (2) loss of autonomy and performing usual activities; (3) balancing energy and mood; (4) intimacy; (5) feeling understood and accepted; (6) meaning of life; and (7) the expectations of iMCS treatment. Conclusions: This is the first qualitative study that describes the suffering of patients with chronic neuropathic pain, and their expectations prior to invasive brain stimulation. Significant themes in the lives of patients with chronic pain have been brought to light. The findings strengthen communication between physicians, caregivers, and patients. Practice Implications: The insights gathered from the interviews create a structured framework for comprehending the values and expectations of patients living with central pain and reveal the impact of symptoms due to the central pain. This knowledge improves the communication between physicians and caregivers on one side and the patient on the other side. Furthermore, the framework enhances the capacity for shared decision-making, particularly in managing expectations related to iMCS.
- Top Cited Papers
- 13 May 2025
- Published by Wiley in Pain Practice
- Vol. 25 (5) , e70044
Lumbar Multifidus Dysfunction and Chronic Low Back Pain: Overview, Therapies, and an Update on the Evidence
Background: Chronic low back pain (CLBP) is a common and harmful medical condition, and in many cases, no specific radiographic cause is identified. Many cases of CLBP are refractory to treatment and will recur after the initial episode. Dysfunction of the lumbar multifidus muscle (LMM) has been increasingly identified as a possible cause of non‐specific CLBP (NSCLP).Methods: A review was conducted on the multifidus anatomy, dysfunction, diagnosis, and treatment literature.Results: Multifidus dysfunction has been increasingly recognized as a potential contributor to the pathogenesis of non‐specific chronic low back pain. Multifidus dysfunction is thought to arise from reflex inhibition stemming from an initial insult, which decreases spinal stability and predisposes patients to further injury. Therapeutic approaches aimed at addressing multifidus dysfunction include traditional conservative management, such as patient education, non‐steroidal anti‐inflammatory drugs, spinal manipulation, and physical therapy. These therapies aim mainly to achieve pain relief. Treatments that restore natural multifidus function include motor control exercises and restorative neurostimulation.Conclusion: Non‐specific chronic low back pain is correlated with multifidus atrophy, fatty infiltration, and abnormal lumbar multifidus muscle function. This finding highlights the need for further research and clinical trials on targeted therapeutic approaches. Existing treatments on the lumbar multifidus muscle include motor control exercises and restorative neurostimulation. Unlike many conventional treatments that primarily provide symptom relief, these therapies aim to restore natural multifidus function, offering a rehabilitative rather than purely palliative approach. Motor control exercises have been shown to improve symptoms in cases of CLBP, but there is mixed evidence of their effectiveness relative to standard physical therapy. Restorative neurostimulation is a promising intervention that has been shown to provide significant, durable improvements to disability and pain. Further research on restorative therapies should be conducted using rigorous control protocols and comparative analyses with other CLBP treatment modalities.
- 13 May 2025
- Published by Wiley in Pain Practice
- Vol. 25 (5) , e70044
Top Cited PapersLumbar Multifidus Dysfunction and Chronic Low Back Pain: Overview, Therapies, and an Update on the Evidence
Background: Chronic low back pain (CLBP) is a common and harmful medical condition, and in many cases, no specific radiographic cause is identified. Many cases of CLBP are refractory to treatment and will recur after the initial episode. Dysfunction of the lumbar multifidus muscle (LMM) has been increasingly identified as a possible cause of non‐specific CLBP (NSCLP).Methods: A review was conducted on the multifidus anatomy, dysfunction, diagnosis, and treatment literature.Results: Multifidus dysfunction has been increasingly recognized as a potential contributor to the pathogenesis of non‐specific chronic low back pain. Multifidus dysfunction is thought to arise from reflex inhibition stemming from an initial insult, which decreases spinal stability and predisposes patients to further injury. Therapeutic approaches aimed at addressing multifidus dysfunction include traditional conservative management, such as patient education, non‐steroidal anti‐inflammatory drugs, spinal manipulation, and physical therapy. These therapies aim mainly to achieve pain relief. Treatments that restore natural multifidus function include motor control exercises and restorative neurostimulation.Conclusion: Non‐specific chronic low back pain is correlated with multifidus atrophy, fatty infiltration, and abnormal lumbar multifidus muscle function. This finding highlights the need for further research and clinical trials on targeted therapeutic approaches. Existing treatments on the lumbar multifidus muscle include motor control exercises and restorative neurostimulation. Unlike many conventional treatments that primarily provide symptom relief, these therapies aim to restore natural multifidus function, offering a rehabilitative rather than purely palliative approach. Motor control exercises have been shown to improve symptoms in cases of CLBP, but there is mixed evidence of their effectiveness relative to standard physical therapy. Restorative neurostimulation is a promising intervention that has been shown to provide significant, durable improvements to disability and pain. Further research on restorative therapies should be conducted using rigorous control protocols and comparative analyses with other CLBP treatment modalities.
- Open Access
- 22 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 2888
Thalamic Microstructural Alterations as Revealed by the T1/T2 Ratio in Chronic Pain Patients
Background/Objectives: Neuroimaging biomarkers could offer more objective measures of the pain experience. This study investigated rT1/T2 maps of the brain as a novel biomarker for chronic pain in patients with central post-stroke pain (PSP) and persistent spinal pain syndrome type 2 (PSPS-II). Methods: Patients with PSP and PSPS-II were retrospectively included alongside healthy controls. Bias correction and intensity normalization were applied to the T1-weighted and T2-weighted images to generate the rT1/T2 maps of the brain. Subsequently, rT1/T2 maps were spatially correlated with neurotransmitter atlases derived from molecular imaging. Results: In total, 15 PSPS-II patients, 11 PSP patients, and 18 healthy controls were included. No significant differences between patient and control demographics were found. Significant decreases in rT1/T2 signal intensity (p < 0.001) were observed in the dorsal and medial part of the thalamus, left caudate nucleus, cuneus, superior frontal gyrus, and dorsal cervicomedullary junction in PSP patients. No significant changes were found in rT1/T2 signal intensity in PSPS-II patients. Significant correlations were found with CB1-, 5HT2a-, and mGluR5-receptor maps (pFDR = 0.003, 0.030, and 0.030, respectively) for the PSP patients and with CB1-, 5HT1a-, 5HT2a-, KappaOp-, and mGluR5-receptor maps (pFDR = 0.003, 0.002, 0.002, 0.003, and 0.002, respectively) in PSPS-II patients. Conclusions: These findings suggest that microstructural alterations occur in the thalamus, cuneus, and dorsal cervicomedullary junction in patients with PSP. The lack of significant findings in rT1/T2 in PSPS-II patients combined with the significant correlations with multiple neurotransmitter maps suggests varying degrees of microstructural deterioration in both chronic pain syndromes, although further research is warranted.
- 22 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 2888
Open AccessThalamic Microstructural Alterations as Revealed by the T1/T2 Ratio in Chronic Pain Patients
Background/Objectives: Neuroimaging biomarkers could offer more objective measures of the pain experience. This study investigated rT1/T2 maps of the brain as a novel biomarker for chronic pain in patients with central post-stroke pain (PSP) and persistent spinal pain syndrome type 2 (PSPS-II). Methods: Patients with PSP and PSPS-II were retrospectively included alongside healthy controls. Bias correction and intensity normalization were applied to the T1-weighted and T2-weighted images to generate the rT1/T2 maps of the brain. Subsequently, rT1/T2 maps were spatially correlated with neurotransmitter atlases derived from molecular imaging. Results: In total, 15 PSPS-II patients, 11 PSP patients, and 18 healthy controls were included. No significant differences between patient and control demographics were found. Significant decreases in rT1/T2 signal intensity (p < 0.001) were observed in the dorsal and medial part of the thalamus, left caudate nucleus, cuneus, superior frontal gyrus, and dorsal cervicomedullary junction in PSP patients. No significant changes were found in rT1/T2 signal intensity in PSPS-II patients. Significant correlations were found with CB1-, 5HT2a-, and mGluR5-receptor maps (pFDR = 0.003, 0.030, and 0.030, respectively) for the PSP patients and with CB1-, 5HT1a-, 5HT2a-, KappaOp-, and mGluR5-receptor maps (pFDR = 0.003, 0.002, 0.002, 0.003, and 0.002, respectively) in PSPS-II patients. Conclusions: These findings suggest that microstructural alterations occur in the thalamus, cuneus, and dorsal cervicomedullary junction in patients with PSP. The lack of significant findings in rT1/T2 in PSPS-II patients combined with the significant correlations with multiple neurotransmitter maps suggests varying degrees of microstructural deterioration in both chronic pain syndromes, although further research is warranted.
- Open Access
- 2 September 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (5) , fcae368
The cingulum: a central hotspot for the battle against chronic intractable pain?
Chronic pain causes a major burden on patient’s lives, in part due to its profound socioeconomic impact. Despite the development of various pharmacological approaches and (minor) invasive treatments, a subset of patients remain refractory, hence why alternative targeted neurosurgical interventions like cingulotomy and deep brain stimulation of the anterior cingulate cortex should be considered in the last resort. Despite clinical evidence supporting the potential of these treatments in the management of chronic intractable pain, physicians remain reluctant on its clinical implementation. This can be partially attributed to the lack of clear overviews summarizing existent data. Hence, this article aims to evaluate the current status of cingulotomy and deep brain stimulation of the anterior cingulate cortex in the treatment of chronic intractable pain, to provide insight in whether these neurosurgical approaches and its target should be reconsidered in the current era. In the current study, a literature searches was performed using the PubMed database. Additional articles were searched manually through reviews or references cited within the articles. After exclusion, 24 and 5 articles remained included in the analysis of cingulotomy and deep brain stimulation of the anterior cingulate cortex, respectively. Results indicate that various surgical techniques have been described for cingulotomy and deep brain stimulation of the anterior cingulate cortex. Cingulotomy is shown to be effective 51–53% and 43–64% of patients with neoplastic and non-neoplastic pain at ≤6 months follow-up, and 82% (9/11) and 76% (90/118) at ≥ 12months follow-up, respectively. With regard to deep brain stimulation of the anterior cingulate cortex, no data on neoplastic pain was reported, however, 59% (10/17) and 57% (8/14) of patients with non-neoplastic pain were considered responders at ≤ 6 months and ≥ 12months follow-up, respectively. The most reported adverse events include change in affect (>6.9%, >29/420) and confusion (>4.8%, >20/420) for cingulotomy, and infection (12.8%, 6/47), seizures (8.5%, 4/47) and decline in semantic fluency (6.4%, 3/47) for deep brain stimulation of the anterior cingulate cortex. It can be concluded that cingulotomy and deep brain stimulation of the anterior cingulate cortex are effective last resort strategies for patients with refractory non-neoplastic and neoplastic pain, especially in case of an affective emotional component. Future research should be performed on the cingulum as a neurosurgical target as it allows for further exploration of promising treatment options for chronic intractable pain.
- 2 September 2024
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 6 (5) , fcae368
Open AccessThe cingulum: a central hotspot for the battle against chronic intractable pain?
Chronic pain causes a major burden on patient’s lives, in part due to its profound socioeconomic impact. Despite the development of various pharmacological approaches and (minor) invasive treatments, a subset of patients remain refractory, hence why alternative targeted neurosurgical interventions like cingulotomy and deep brain stimulation of the anterior cingulate cortex should be considered in the last resort. Despite clinical evidence supporting the potential of these treatments in the management of chronic intractable pain, physicians remain reluctant on its clinical implementation. This can be partially attributed to the lack of clear overviews summarizing existent data. Hence, this article aims to evaluate the current status of cingulotomy and deep brain stimulation of the anterior cingulate cortex in the treatment of chronic intractable pain, to provide insight in whether these neurosurgical approaches and its target should be reconsidered in the current era. In the current study, a literature searches was performed using the PubMed database. Additional articles were searched manually through reviews or references cited within the articles. After exclusion, 24 and 5 articles remained included in the analysis of cingulotomy and deep brain stimulation of the anterior cingulate cortex, respectively. Results indicate that various surgical techniques have been described for cingulotomy and deep brain stimulation of the anterior cingulate cortex. Cingulotomy is shown to be effective 51–53% and 43–64% of patients with neoplastic and non-neoplastic pain at ≤6 months follow-up, and 82% (9/11) and 76% (90/118) at ≥ 12months follow-up, respectively. With regard to deep brain stimulation of the anterior cingulate cortex, no data on neoplastic pain was reported, however, 59% (10/17) and 57% (8/14) of patients with non-neoplastic pain were considered responders at ≤ 6 months and ≥ 12months follow-up, respectively. The most reported adverse events include change in affect (>6.9%, >29/420) and confusion (>4.8%, >20/420) for cingulotomy, and infection (12.8%, 6/47), seizures (8.5%, 4/47) and decline in semantic fluency (6.4%, 3/47) for deep brain stimulation of the anterior cingulate cortex. It can be concluded that cingulotomy and deep brain stimulation of the anterior cingulate cortex are effective last resort strategies for patients with refractory non-neoplastic and neoplastic pain, especially in case of an affective emotional component. Future research should be performed on the cingulum as a neurosurgical target as it allows for further exploration of promising treatment options for chronic intractable pain.
- Open Access
- 11 July 2024
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 27 (6) , 1055-1061
Preoperative Counseling in Spinal Cord Stimulation: A Designated Driver in Implantable Pulse Generator–Related Inconveniences?
- 11 July 2024
- Published by Elsevier in Neuromodulation: Technology at the Neural Interface
- Vol. 27 (6) , 1055-1061
Open AccessPreoperative Counseling in Spinal Cord Stimulation: A Designated Driver in Implantable Pulse Generator–Related Inconveniences?
- Open Access
- 22 March 2024
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 9 (2) , e1149
Cingulotomy: the last man standing in the battle against medically refractory poststroke pain
Introduction: Central poststroke pain (CPSP) places a huge burden on patient lives because patients are often refractory to conventional strategies and have little chance for spontaneous recovery. A subset of patients is even given approval for euthanasia and is without any perspective. Because the anterior cingulate cortex historically seems to be a promising target for patients with both mental and chronic pain disorders, lesioning of this central “hub” with cingulotomy may be a useful strategy for medically refractory CPSP. However, limited research is available on cingulotomy for central pain. Hence, we represent a rare case in which cingulotomy is performed on a patient with CPSP. Objectives: To describe the potential of cingulotomy in a case with CPSP. Methods: The case presented in this study concerns a 60-year-old woman who experienced CPSP, caused by a hemorrhagic stroke in the basal ganglia and thalamus. The patient visited several centers and tried multiple off-label treatments; however, she was told nothing else could be done and was even given approval for euthanasia. Hence, anterior cingulotomy was performed. Results: After surgery, no transient adverse events occurred, except for vocabulary disturbances post stroke, which disappeared after several weeks. After 14 weeks, changes in pain behavior were observed, followed by a decreased pain intensity. At a later follow-up, the pain had completely disappeared. Conclusion: Anterior cingulotomy seems to be a suitable “last-resort” option for patients with CPSP. Future research, including homogenous groups, to define the best location for lesioning is required to allow the revival of this “old” technique in the current era.
- 22 March 2024
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 9 (2) , e1149
Open AccessCingulotomy: the last man standing in the battle against medically refractory poststroke pain
Introduction: Central poststroke pain (CPSP) places a huge burden on patient lives because patients are often refractory to conventional strategies and have little chance for spontaneous recovery. A subset of patients is even given approval for euthanasia and is without any perspective. Because the anterior cingulate cortex historically seems to be a promising target for patients with both mental and chronic pain disorders, lesioning of this central “hub” with cingulotomy may be a useful strategy for medically refractory CPSP. However, limited research is available on cingulotomy for central pain. Hence, we represent a rare case in which cingulotomy is performed on a patient with CPSP. Objectives: To describe the potential of cingulotomy in a case with CPSP. Methods: The case presented in this study concerns a 60-year-old woman who experienced CPSP, caused by a hemorrhagic stroke in the basal ganglia and thalamus. The patient visited several centers and tried multiple off-label treatments; however, she was told nothing else could be done and was even given approval for euthanasia. Hence, anterior cingulotomy was performed. Results: After surgery, no transient adverse events occurred, except for vocabulary disturbances post stroke, which disappeared after several weeks. After 14 weeks, changes in pain behavior were observed, followed by a decreased pain intensity. At a later follow-up, the pain had completely disappeared. Conclusion: Anterior cingulotomy seems to be a suitable “last-resort” option for patients with CPSP. Future research, including homogenous groups, to define the best location for lesioning is required to allow the revival of this “old” technique in the current era.
- Open Access
- 7 November 2023
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 63 (10) , 1458-1461
A qualitative study on the long‐term effectiveness of occipital nerve stimulation in patients with chronic cluster headache
- 7 November 2023
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 63 (10) , 1458-1461
Open AccessA qualitative study on the long‐term effectiveness of occipital nerve stimulation in patients with chronic cluster headache
- Open Access
- 15 March 2023
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 162 (1) , 225-235
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol
Purpose: Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch treatment protocol for adult medulloblastoma patients. Methods: Adult medulloblastoma patients diagnosed between 2010 and 2018 were identified in the Dutch rare tumors registry or nationwide pathology database. Patients with intention to treat according to the national treatment protocol were included. Risk stratification was performed based on residual disease, histological subtype and extent of disease. All patients received postoperative radiotherapy [craniospinal axis 36 Gy/fossa posterior boost 19.8 Gy (14.4 Gy in case of metastases)]. High-risk patients received additional neoadjuvant (carboplatin-etoposide), concomitant (vincristine) and adjuvant chemotherapy (carboplatin-vincristine-cyclophosphamide) as far as feasible by toxicity. Methylation profiling, and additional next-generation sequencing in case of SHH-activated medulloblastomas, were performed. Results: Forty-seven medulloblastoma patients were identified, of whom 32 were treated according to the protocol. Clinical information and tumor material was available for 28 and 20 patients, respectively. The histological variants were mainly classic (43%) and desmoplastic medulloblastoma (36%). Sixteen patients (57%) were considered standard-risk and 60% were SHH-activated medulloblastomas. Considerable treatment reductions and delays in treatment occurred due to especially hematological and neurotoxicity. Only one high-risk patient could complete all chemotherapy courses. 5-years progression-free survival (PFS) and overall survival (OS) for standard-risk patients appeared worse than for high-risk patients (PFS 69% vs. 90%, OS 81% vs. 90% respectively), although this wasn’t statistically significant. Conclusion: Combined chemo-radiotherapy is a toxic regimen for adult medulloblastoma patients that may result in improved survival.
- 15 March 2023
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 162 (1) , 225-235
Open AccessMedulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol
Purpose: Medulloblastoma is a rare tumor in adults. The objective of this nationwide, multicenter study was to evaluate the toxicity and efficacy of the Dutch treatment protocol for adult medulloblastoma patients. Methods: Adult medulloblastoma patients diagnosed between 2010 and 2018 were identified in the Dutch rare tumors registry or nationwide pathology database. Patients with intention to treat according to the national treatment protocol were included. Risk stratification was performed based on residual disease, histological subtype and extent of disease. All patients received postoperative radiotherapy [craniospinal axis 36 Gy/fossa posterior boost 19.8 Gy (14.4 Gy in case of metastases)]. High-risk patients received additional neoadjuvant (carboplatin-etoposide), concomitant (vincristine) and adjuvant chemotherapy (carboplatin-vincristine-cyclophosphamide) as far as feasible by toxicity. Methylation profiling, and additional next-generation sequencing in case of SHH-activated medulloblastomas, were performed. Results: Forty-seven medulloblastoma patients were identified, of whom 32 were treated according to the protocol. Clinical information and tumor material was available for 28 and 20 patients, respectively. The histological variants were mainly classic (43%) and desmoplastic medulloblastoma (36%). Sixteen patients (57%) were considered standard-risk and 60% were SHH-activated medulloblastomas. Considerable treatment reductions and delays in treatment occurred due to especially hematological and neurotoxicity. Only one high-risk patient could complete all chemotherapy courses. 5-years progression-free survival (PFS) and overall survival (OS) for standard-risk patients appeared worse than for high-risk patients (PFS 69% vs. 90%, OS 81% vs. 90% respectively), although this wasn’t statistically significant. Conclusion: Combined chemo-radiotherapy is a toxic regimen for adult medulloblastoma patients that may result in improved survival.